Analyzing a cancer biopsy requires tools that can capture its full complexity, especially when working with preserved FFPE samples. At STOmics, our team developed the STOmics OMNI platform to meet this need. This integrated FFPE Transcriptomics Solution, Stereo-seq OMNI V1.1, is designed to unlock the detailed spatial architecture of archived tissue. For researchers, this opens specific, actionable pathways. We detail five options for analysis that this technology enables.

 Multi-Omic Visualization of the Tumor Ecosystem

The initial option provided by the STOmics OMNI platform is foundational: direct visualization. Our FFPE transcriptomics solution allows you to see the simultaneous expression of genes and proteins on a single tissue section. This creates a map where RNA signals and protein localization are overlaid on the high-resolution biopsy image. Observing this correlation offers an immediate understanding of molecular relationships within the tumor's spatial context, from the core to the invasive margin.

Mapping Intratumoral Heterogeneity

A significant application is mapping spatial heterogeneity. The data from the STOmics OMNI platform enables you to identify and characterize distinct molecular subclones within a tumor based on their combined transcriptomic and proteomic profiles. You can locate where these subpopulations reside and analyze their unique microenvironment. This option is critical for understanding tumor evolution, pinpointing niches of aggressive cells, and identifying regions that may harbor resistance mechanisms.

Profiling the Tumor-Immune Interface

The third option focuses on the immune landscape. Using the FFPE Transcriptomics Solution, you can profile the complex spatial interplay between tumor cells and various immune cell types. By analyzing specific RNA and protein markers in situ, you can classify immune-rich or immune-excluded regions, characterize the functional state of infiltrating lymphocytes, and spatially map immunosuppressive signals. This analysis provides a systems-level view of the tumor-immune microenvironment.

 Analyzing Morphological Transition Zones

The fourth option involves studying critical tissue boundaries. The STOmics OMNI platform is effective for analyzing transitional areas, such as the interface between tumor and normal tissue, or the edges of metastatic foci. You can investigate the coordinated changes in gene and protein expression across these borders. This can reveal mechanisms of invasion, identify early warning signatures in adjacent normal tissue, and define the molecular gradient that drives cancer spread.

 Validating Diagnostic and Prognostic Biomarkers

The fifth option centers on translational validation. For candidate biomarkers identified in bulk studies, the STOmics OMNI platform allows for spatial confirmation. You can verify whether a biomarker's RNA expression aligns with its protein abundance directly within the intact tissue architecture of an FFPE block. Furthermore, you can assess the biomarker's specificity to certain cell types or regions, strengthening its diagnostic or prognostic value through precise spatial context.

The STOmics OMNI platform, as our advanced FFPE Transcriptomics Solution, provides these five analytical options to deepen the investigation of cancer biopsies. From initial visualization to detailed mapping of heterogeneity, immune context, invasive zones, and biomarker validation, each pathway leverages the power of integrated spatial multi-omics. We at STOmics are committed to providing researchers with precise tools like the STOmics OMNI system to extract definitive insights from every sample.